Scientific News The Body Scientific Psychedelic Drugs For Depression And Anxiety Part One
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News The Body Scientific Psychedelic Drugs For Depression And Anxiety Part One is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
'One and done' dose of LSD keeps anxiety at bay
A rigorous new study finds that a single dose of LSD can ease anxiety and depression for months. The study involved 198 adults with generalized anxiety disorder, or GAD, a disabling form of anxiety ... Read More
Single psilocybin trip delivers two years of depression relief for cancer patients
Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in cancer patients. In a groundbreaking trial, a single dose combined with therapy ... Read More
Psychedelic drug popular in 1960s could ease anxiety as doctors share warnings
A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical ... Read More
Just one single dose of ‘magic mushrooms’ could relieve depression for 5 years, researchers find
Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after just one dose, according to a new study. The research, presented June 18 at ... Read More
LSD Could Offer a Next-Gen Treatment for Anxiety
One person’s acid trip could be another person’s anxiety therapy. That’s the tantalizing upshot from a new study that showed LSD may have the potential to alleviate anxiety. The findings are just the ... Read More
LSD shows promise for reducing anxiety in drugmaker's midstage study
LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ... Read More
Texas politicians lead effort to study a psychedelic drug. What is ibogaine?
A once obscure traditional psychedelic plant from Africa has made headlines recently as Texas pushes for more research and a prominent Republican wrote a vigorous endorsement of its possible use for ... Read More
Psychedelic-Assisted Therapy Offers New Hope for Veterans
(Family Features) For generations, America’s veterans have borne not only the visible scars of battle but also the hidden wounds of war. Post-traumatic stress disorder (PTSD), depression, traumatic ... Read More
Atai rises as psychedelic drug succeeds in mid-stage trial for depression
Shares of atai Life Sciences (NASDAQ:ATAI) traded higher in the premarket on Tuesday after the company and its partner, Beckley Psytech Limited, said their jointly developed psychedelic drug BPL-003 ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus